Aurora Cannabis: High-Margin Derivative Products Accelerating European Revenue Growth

March, 11, 2019   High-Margin Derivative Products Accelerating European Revenue Growth TSX | NYSE: ACB   EDMONTON, March 11, 2019 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has commenced sales of cannabis oils to German pharmacies following receipt of all necessary approvals

Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership

February, 26, 2019 Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora’s International Footprint to 24 Countries   EDMONTON, Feb. 26, 2019 /CNW/ – Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has agreed to terms to acquire